ND 630 is primarily used in the field of biochemistry and pharmacology for its role in targeting and modulating specific metabolic pathways. It is particularly studied for its potential in managing conditions related to lipid metabolism, such as obesity and non-alcoholic fatty liver disease (NAFLD). By inhibiting key enzymes involved in fat production, ND 630 helps reduce the accumulation of lipids in the liver and other tissues, thereby improving metabolic health. Additionally, it is being explored for its therapeutic effects in diabetes management, as it may enhance insulin sensitivity and regulate blood glucose levels. Ongoing research also investigates its potential in cardiovascular health, where it could aid in reducing risk factors associated with heart disease. Its application in these areas highlights its significance as a promising compound in metabolic and chronic disease research.